Discover

ENSC
Ensysce Biosciences, Inc.
0.30
2 x 0.21
2 x 0.37
bid
ask
+
0.01
4.03%
2 @ 04:52 AM
0.29 -0.01 (4.28%)
Ytd-67.21%
1y-86.53%
0.29
day range
0.30
0.23
52 week range
2.75
Open0.29Prev Close0.29Low0.29High0.30Mkt Cap4.64M
Vol298.13KAvg Vol2.23MEPS-3.11P/EN/AForward P/E-9.08
Beta0.64Short Ratio0.12Inst. Own22.26%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1450-d Avg0.32200-d Avg1.031yr Est102.00
Income Statement
Operating Expenses3.56M
Research and Development Expense3.35M
Selling, General and Administrative Expense1.18M
Operating Income-3.56M
Interest Expense3.92K
Net Income-3.56M
Net Income Common Stock-3.56M
Net Income Common Stock (USD)-3.56M
Consolidated Income-3.56M
Earnings per Basic Share-0.52
Earnings per Basic Share (USD)-0.52
Earnings per Diluted Share-0.52
Earning Before Interest & Taxes (EBIT)-3.55M
Earning Before Interest & Taxes (USD)-3.55M
Weighted Average Shares6.84M
Weighted Average Shares Diluted6.84M
Balance Sheet
Cash and Equivalents745.48K
Cash and Equivalents (USD)745.48K
Current Assets2.01M
Property, Plant & Equipment Net117.60K
Total Assets2.17M
Debt Current245.85K
Total Debt245.85K
Current Liabilities2.84M
Total Liabilities2.84M
Accumulated Retained Earnings (Deficit)-143.28M
Shareholders Equity-340.04K
Shareholders Equity (USD)-340.04K
Assets Non-Current159.26K
Total Debt (USD)245.85K
Trade and Non-Trade Payables1.61M
Cash Flow
Depreciation, Amortization & Accretion6.53K
Net Cash Flow from Financing-63.95K
Net Cash Flow / Change in Cash & Cash Equivalents-3.56M
Issuance (Repayment) of Debt Securities -63.95K
Net Cash Flow from Operations-3.50M
Share Based Compensation8.74K